» Articles » PMID: 12792544

Revascularization of Human Acellular Dermis in Full-thickness Abdominal Wall Reconstruction in the Rabbit Model

Overview
Journal Ann Plast Surg
Specialty General Surgery
Date 2003 Jun 7
PMID 12792544
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigates whether human acellular dermis (Alloderm; LifeCell, Branchburg, NJ) revascularizes when used to reconstruct abdominal wall defects in rabbits. This could prove useful in infected situations in which prosthetic mesh is suboptimal. Twenty-five rabbits were randomly assigned to one of three groups: primary closure (n = 5), expanded polytetrafluoroethylene (GoreTex; W.L. Gore, Flagstaff, AZ) repair (n = 10), or AlloDerm (LifeCell) repair (n = 10). The rabbits in the primary closure group received a 7 cm x 0.5 cm full-thickness abdominal wall defect that was closed primarily. A 7 cm x 3 cm full-thickness abdominal wall defect was created in the other two groups. The defects were repaired with a GoreTex Mycromesh (W.L. Gore), or AlloDerm (LifeCell) patch. At 30 days, the following endpoints were evaluated: (1) incidence of herniation; (2) presence of intra-abdominal adhesions; (3) the breaking strength of the patch-fascial interface; and (4) evaluation of graft vascularization by fluorescein dye infusion and histological analysis. There was no incidence of herniation in any of the rabbits. Visceral adhesions to the patch were found in all animals in the Gore-Tex (W.L. Gore) group but in none in the AlloDerm (LifeCell) group. The size of the patch was unchanged in all the rabbits except for two rabbits in the AlloDerm (LifeCell) group that stretched 1 cm in the transverse dimension. The change in size was not statistically significant (p = 0.17) when compared with the change in size in the Gore-Tex (W.L. Gore) group. The mean breaking strength of the primary closure group was significantly higher (521.2 N/mm2 +/- 223.0) than that of the two patch-repair groups (p < 0.05). But there was no significant difference between the mean breaking strength of the AlloDerm (LifeCell) fascial interface (288.6 N/mm2 +/- 97.1 SD) and that of the Gore-Tex (W.L. Gore) fascial interface (337.0 N/mm2 +/- 141.2). Fluorescein dye infusion and histological analysis confirmed vascularization of the AlloDerm (LifeCell) graft. This study demonstrates that AlloDerm (LifeCell) does become vascularized when used as a fascial interposition graft for abdominal wall reconstruction. AlloDerm (LifeCell) also performs mechanically as effectively as Gore-Tex (W.L. Gore) in ventral hernia repair at 1 month after operation in the rabbit model.

Citing Articles

A systematic review and meta-analysis of randomized controlled trials for the management of ventral hernia: biologic versus synthetic mesh.

Alzahrani A, Alhindi N, Alotaibi S, Alzibali K, Alaqla A, Alzahrani S Updates Surg. 2024; 76(8):2725-2731.

PMID: 39369143 DOI: 10.1007/s13304-024-02001-3.


Improvement in Biocompatibility and Biointegration of Human Acellular Dermal Matrix through Vacuum Plasma Surface Treatment.

Yang H, Lee B, Shin C, You B, Oh H, Lee J Bioengineering (Basel). 2024; 11(4).

PMID: 38671781 PMC: 11047967. DOI: 10.3390/bioengineering11040359.


The Autonomization Principle in Vascularized Flaps: An Alternative Strategy for Composite Tissue Scaffold In Vivo Revascularization.

Berkane Y, Kostyra D, Chrelias T, Randolph M, Lellouch A, Cetrulo Jr C Bioengineering (Basel). 2023; 10(12).

PMID: 38136031 PMC: 10740989. DOI: 10.3390/bioengineering10121440.


Post-Implantation Inflammatory Responses to Xenogeneic Tissue-Engineered Cartilage Implanted in Rabbit Trachea: The Role of Cultured Chondrocytes in the Modification of Inflammation.

Klabukov I, Atiakshin D, Kogan E, Ignatyuk M, Krasheninnikov M, Zharkov N Int J Mol Sci. 2023; 24(23).

PMID: 38069106 PMC: 10706106. DOI: 10.3390/ijms242316783.


Outcomes of Complex Abdominal Wall Reconstruction with Biologic Mesh in Patients with 8 Years of Follow-Up.

Hassan A, Franco C, Shah N, Talanker M, Asaad M, Mericli A World J Surg. 2023; 47(12):3175-3181.

PMID: 37667067 DOI: 10.1007/s00268-023-07154-7.